| Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein B De Strooper, P Saftig, K Craessaerts, H Vanderstichele, G Guhde, ... Nature 391 (6665), 387-390, 1998 | 2455 | 1998 |
| Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects LM Shaw, H Vanderstichele, M Knapik‐Czajka, CM Clark, PS Aisen, ... Annals of neurology 65 (4), 403-413, 2009 | 2236 | 2009 |
| Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF F Hulstaert, K Blennow, A Ivanoiu, HC Schoonderwaldt, ... Neurology 52 (8), 1555-1555, 1999 | 939 | 1999 |
| Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice N Andreasen, L Minthon, P Davidsson, E Vanmechelen, H Vanderstichele, ... Archives of neurology 58 (3), 373-379, 2001 | 771 | 2001 |
| Cerebrospinal fluid β-amyloid (1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease N Andreasen, C Hesse, P Davidsson, L Minthon, A Wallin, B Winblad, ... Archives of neurology 56 (6), 673-680, 1999 | 765 | 1999 |
| Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 … A Herreman, D Hartmann, W Annaert, P Saftig, K Craessaerts, L Serneels, ... Proceedings of the National Academy of Sciences 96 (21), 11872-11877, 1999 | 619 | 1999 |
| Measurement of phosphorylated tau epitopes in the differential diagnosisof Alzheimer disease: a comparative cerebrospinal fluid study H Hampel, K Buerger, R Zinkowski, SJ Teipel, A Goernitz, N Andreasen, ... Archives of general psychiatry 61 (1), 95-102, 2004 | 587 | 2004 |
| Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization E Vanmechelen, H Vanderstichele, P Davidsson, E Van Kerschaver, ... Neuroscience letters 285 (1), 49-52, 2000 | 559 | 2000 |
| Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke C Hesse, L Rosengren, N Andreasen, P Davidsson, H Vanderstichele, ... Neuroscience letters 297 (3), 187-190, 2001 | 542 | 2001 |
| Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people G De Meyer, F Shapiro, H Vanderstichele, E Vanmechelen, ... Archives of neurology 67 (8), 949-956, 2010 | 530 | 2010 |
| Tau and Aβ42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values M Sjogren, H Vanderstichele, H Ågren, O Zachrisson, M Edsbagge, ... Clinical chemistry 47 (10), 1776-1781, 2001 | 522 | 2001 |
| Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology A Olsson, H VANDERSticHELE, N Andreasen, G De Meyer, A WALLiN, ... Clinical chemistry 51 (2), 336-345, 2005 | 494 | 2005 |
| CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease S Janelidze, H Zetterberg, N Mattsson, S Palmqvist, H Vanderstichele, ... Annals of clinical and translational neurology 3 (3), 154-165, 2016 | 425 | 2016 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 425 | 2011 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 397 | 2013 |
| Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma H Vanderstichele, EV Kerschaver, C Hesse, P Davidsson, MA Buyse, ... Amyloid 7 (4), 245-258, 2000 | 385 | 2000 |
| Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers … H Vanderstichele, M Bibl, S Engelborghs, N Le Bastard, P Lewczuk, ... Alzheimer's & Dementia 8 (1), 65-73, 2012 | 361 | 2012 |
| Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment O Hansson, H Zetterberg, E Vanmechelen, H Vanderstichele, ... Neurobiology of aging 31 (3), 357-367, 2010 | 352 | 2010 |
| Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment N Andreasen, L Minthon, E Vanmechelen, H Vanderstichele, P Davidsson, ... Neuroscience letters 273 (1), 5-8, 1999 | 325 | 1999 |
| Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia S Engelborghs, K De Vreese, T Van de Casteele, H Vanderstichele, ... Neurobiology of aging 29 (8), 1143-1159, 2008 | 324 | 2008 |
